This document is an excerpt from the EUR-Lex website
Document 62019TN0184
Case T-184/19: Action brought on 27 March 2019 — Aurea Biolabs v EUIPO — Avizel (AUREA BIOLABS)
Case T-184/19: Action brought on 27 March 2019 — Aurea Biolabs v EUIPO — Avizel (AUREA BIOLABS)
Case T-184/19: Action brought on 27 March 2019 — Aurea Biolabs v EUIPO — Avizel (AUREA BIOLABS)
OJ C 172, 20.5.2019, p. 43–44
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
20.5.2019 |
EN |
Official Journal of the European Union |
C 172/43 |
Action brought on 27 March 2019 — Aurea Biolabs v EUIPO — Avizel (AUREA BIOLABS)
(Case T-184/19)
(2019/C 172/57)
Language of the case: English
Parties
Applicant: Aurea Biolabs Pte Ltd (Cochin, India) (represented by: B. Brandreth, QC and L. Oommen, Solicitor)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Avizel SA (Luxembourg, Luxembourg)
Details of the proceedings before EUIPO
Applicant of the trade mark at issue: Applicant before the General Court
Trade mark at issue: Application for figurative mark AUREA BIOLABS — Application for registration No 15 836 737
Procedure before EUIPO: Opposition proceedings
Contested decision: Decision of the Second Board of Appeal of EUIPO of 29 January 2019 in Case R 814/2018-2 (CORR)
Form of order sought
The applicant claims that the Court should:
|
— |
annul the contested decision; |
|
— |
order the payment of the Applicant’s costs. |
Pleas in law
|
— |
In support of its decision, the Board of Appeal relies on an invalid provision of law; |
|
— |
Had there been an obvious error of law, the appropriate course was to revoke the previous decision; |
|
— |
Infringement of Article 94(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council and of the principles of natural justice. |